BIOMAT Database Logo BIOMAT Database Logo

Improved renal allograft survival for AHG and DTE/AHG crossmatch-negative recipients. 1991

R H Kerman, and P M Kimball, and C T Van Buren, and R M Lewis, and V DeVera, and V Baghdahsarian, and A Heydari, and B D Kahan
Department of Surgery, University of Texas Medical School, Houston 77030.

UI MeSH Term Description Entries
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D004226 Dithioerythritol A compound that, along with its isomer, Cleland's reagent (DITHIOTHREITOL), is used for the protection of sulfhydryl groups against oxidation to disulfides and for the reduction of disulfides to sulfhydryl groups. 2,3-Dihydroxy-1,4-dithiolbutane,Dithioerythreitol
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

R H Kerman, and P M Kimball, and C T Van Buren, and R M Lewis, and V DeVera, and V Baghdahsarian, and A Heydari, and B D Kahan
Improved graft survival in 100 retransplant recipients following AHG-negative crossmatching.
January 1997, Transplantation proceedings,
R H Kerman, and P M Kimball, and C T Van Buren, and R M Lewis, and V DeVera, and V Baghdahsarian, and A Heydari, and B D Kahan
Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients.
January 1990, Transplantation,
R H Kerman, and P M Kimball, and C T Van Buren, and R M Lewis, and V DeVera, and V Baghdahsarian, and A Heydari, and B D Kahan
Improved patient and primary renal allograft survival in uremic diabetic recipients.
December 1982, Transplantation,
R H Kerman, and P M Kimball, and C T Van Buren, and R M Lewis, and V DeVera, and V Baghdahsarian, and A Heydari, and B D Kahan
Improved cadaver allograft survival in transfused recipients who remain serologically negative for cytomegalovirus.
April 1982, The Journal of urology,
R H Kerman, and P M Kimball, and C T Van Buren, and R M Lewis, and V DeVera, and V Baghdahsarian, and A Heydari, and B D Kahan
Improved renal allograft survival for pre-emptive paediatric renal transplant recipients in the UK.
December 2021, Archives of disease in childhood,
R H Kerman, and P M Kimball, and C T Van Buren, and R M Lewis, and V DeVera, and V Baghdahsarian, and A Heydari, and B D Kahan
A past positive crossmatch does not affect allograft survival for cyclosporine-immunosuppressed primary and secondary renal transplant recipients.
February 1989, Transplantation proceedings,
R H Kerman, and P M Kimball, and C T Van Buren, and R M Lewis, and V DeVera, and V Baghdahsarian, and A Heydari, and B D Kahan
Positive antiglobulin cytotoxicity crossmatch in renal allograft recipients treated with cyclosporine.
October 1986, Transplantation,
R H Kerman, and P M Kimball, and C T Van Buren, and R M Lewis, and V DeVera, and V Baghdahsarian, and A Heydari, and B D Kahan
Successful renal allografts in recipients with a positive standard, DTE negative cross-match.
February 1989, Transplantation proceedings,
R H Kerman, and P M Kimball, and C T Van Buren, and R M Lewis, and V DeVera, and V Baghdahsarian, and A Heydari, and B D Kahan
Does flow cytometry crossmatch predict renal allograft outcome in patients with a negative antiglobulin crossmatch?
March 2007, Nature clinical practice. Nephrology,
R H Kerman, and P M Kimball, and C T Van Buren, and R M Lewis, and V DeVera, and V Baghdahsarian, and A Heydari, and B D Kahan
Renal allograft outcome in recipients of positive-crossmatch combined liver-kidney transplantation.
November 2013, Transplantation proceedings,
Copied contents to your clipboard!